Lyell Immunopharma, Inc. (LYEL)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
13. 32
-0.57
-4.1037%
$
312.68M Market Cap
- P/E Ratio
- Div Yield
168,700 Volume
-0.85 Eps
$ 13.89
Previous Close Investors:
Want to track LYEL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Lyell Immunopharma, Inc. (LYEL) Statistics
Valuation metrics
Market Cap 312.68M
Enterprise value 268.89M
Trailing P/E (ttm) -0.78
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 10,026.13
Price/Book (mrq) 1.06
Enterprise Value/Revenue 8,673.9
Enterprise Value/EBITDA -1.13
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 147.4K
Average volume (90 days) 138.51K
Price summary
52-Week low 9.11
52-Week high 45
Beta -
50-Day moving average 13.38
200-Day moving average 21.69
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 2 Jun 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -7,948.58%
Operating margin -6,189.1%
Operational effectiveness
Return on assets -0.7%
Return on equity -0.86%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -11.26
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 11.61
Total debt (mrq) -
Total Debt/Equity (mrq) 0.18
Current ratio (mrq) 7.23%
Book value per share (mrq) 12.51
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
